The Phase 3 study is detailed at http://www.clinicaltrials.gov/ct2/show/NCT00273364?term=Stem+Cell+Therapy+for+Patients+With+Multiple+Sclerosis+Failing+Alternate+Approved+Therapy&rank=1
Read the acceptance criteria carefully to see if you might qualify. Then apply to:
| Contact: Dzemila Spahovic, MD | 312-695-4960 | d-spahovic@northwestern.edu |
According to Dr. Burt, the ideal candidate for this treatment is an MS patient who is still in the relapsing-remitting stage of the disease, experiencing relapses, failing conventional MS drug therapies and showing enhancing lesions on an MRI scan. I fit all those criteria and was accepted in Chicago. Research studies may or may not be currently recruiting patients. They can close at any time. It's best to call or email directly to the program to determine their current research needs and to explain your current condition.
Other programs around the world also offer HSCT for MS. Each has their own unique criteria of patient acceptance and cost. Some will treat patients without participation in a research study. Thanks to HSCT advocate Gina Metichecchia Tiel for compiling the following resource list.
To learn more about this treatment, go to THEMSCURE.BLOGSPOT.COM or request an invitation to join two Facebook Forums dedicated to HSCT treatment:
Hematopioetic Stem Cell Transplant – MS & Autoimmune Diseases
Dr. Richard K. Burt Stem Cell Study (HSCT) Chicago
Worldwide facilities performing HSCT for MS and other Autoimmune Disorders:
USA – DIAD: Division of Immunotherapy and Autoimmune Diseases
CANADA – Ottawa General Hospital
DENMARK – Rigshospitalet
GERMANY – UniversitätsKlinikum Heidelberg
INDIA – Manipal International Patient Care Center
ISRAEL – CTCI: International Center for Cell Therapy and Cancer Immunotherapy
ITALY – Careggi University Hospital of Florence
RUSSIA – National Pirogov Medical Surgical Center
SOUTH AFRICA – UCT Private Academic Hospital
SWEDEN – Stockholm Care AB
No comments:
Post a Comment